Modulating T cell responses for the treatment of psoriasis: a focus on efalizumab

By Cather Jennifer Clay   Cather J Christian   Menter Alan  

Expert Opinion on Biological Therapy, Vol. 3, Iss. 2, 2003-04 ,pp. : 361-370

Informa Healthcare

Access to resources Recommend Favorite

Immunogenicity of anti-TNFα therapy in psoriasis: a clinical issue?

By De Simone Clara   Amerio Paolo   Amoruso Giuseppe   Bardazzi Federico   Campanati Anna   Conti Andrea   Gisondi Paolo   Gualdi Giulio   Guarneri Claudio   Leoni Luca   Loconsole Francesco   Mazzotta Annamaria   Musumeci Maria Letizia   Piaserico Stefano   Potenza Concetta   Prestinari Francesca  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 12, 2013-12 ,pp. : 1673-1682

Informa Healthcare

Access to resources Recommend Favorite

Gene therapy for chronic granulomatous disease

By Barese Cecilia N   Goebel W Scott   Dinauer Mary C  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 9, 2004-09 ,pp. : 1423-1434

Informa Healthcare

Access to resources Recommend Favorite

Selective targeting of T cell subsets: focus on alefacept – a remittive therapy for psoriasis

By Krueger Gerald G  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 4, 2002-04 ,pp. : 431-441

Informa Healthcare

Access to resources Recommend Favorite

Continuous health monitoring: integrating biomarkers for the management of chronic diseases

By Gruson Damien   Gouget Bernard  

Biomarkers, Vol. 17, Iss. 7, 2012-11 ,pp. : 668-670

Informa Healthcare

Access to resources Recommend Favorite